A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption

D. Bilsland; S. A. George; N. K. Gibbs; T. Aitchison; B. E. Johnson; J. Ferguson

doi:10.1111/j.1365-2133.1993.tb03337.x

A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption

D. Bilsland
, S. A. George
, N. K. Gibbs
, T. Aitchison
, B. E. Johnson
, J. Ferguson

Research output: Contribution to journal › Article › peer-review

Abstract

Twenty-five patients suffering from severe polymorphic light eruption (PLE) were randomized to either photochemotherapy (PUVA) or narrow-band phototherapy (TL-01 UVB) treatment in early spring; patients receiving UVB were given placebo tablets to achieve a matching therapy procedure. During the 4 months following treatment, patient exposure to solar UVB was monitored with polysulphone badges. PLE occurrence, severity, and restriction of outdoor activity were recorded, using weekly diary-sheets. Analysis of covariance on this data, using the logarithm of UVB exposure as the explanatory variable, showed no significant differences between the treatments. TL-01 UVB is an effective alternative to PUVA in the management of PLE.

Original language	English
Pages (from-to)	708-712
Number of pages	4
Journal	British Journal of Dermatology
Volume	129
Issue number	6
DOIs	https://doi.org/10.1111/j.1365-2133.1993.tb03337.x
Publication status	Published - 1993

Access to Document

10.1111/j.1365-2133.1993.tb03337.x

Cite this

@article{beb30de5f4604d128258c2dd8cb41de3,

title = "A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption",

abstract = "Twenty-five patients suffering from severe polymorphic light eruption (PLE) were randomized to either photochemotherapy (PUVA) or narrow-band phototherapy (TL-01 UVB) treatment in early spring; patients receiving UVB were given placebo tablets to achieve a matching therapy procedure. During the 4 months following treatment, patient exposure to solar UVB was monitored with polysulphone badges. PLE occurrence, severity, and restriction of outdoor activity were recorded, using weekly diary-sheets. Analysis of covariance on this data, using the logarithm of UVB exposure as the explanatory variable, showed no significant differences between the treatments. TL-01 UVB is an effective alternative to PUVA in the management of PLE.",

author = "D. Bilsland and George, \{S. A.\} and Gibbs, \{N. K.\} and T. Aitchison and Johnson, \{B. E.\} and J. Ferguson",

year = "1993",

doi = "10.1111/j.1365-2133.1993.tb03337.x",

language = "English",

volume = "129",

pages = "708--712",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption

AU - Bilsland, D.

AU - George, S. A.

AU - Gibbs, N. K.

AU - Aitchison, T.

AU - Johnson, B. E.

AU - Ferguson, J.

PY - 1993

Y1 - 1993

N2 - Twenty-five patients suffering from severe polymorphic light eruption (PLE) were randomized to either photochemotherapy (PUVA) or narrow-band phototherapy (TL-01 UVB) treatment in early spring; patients receiving UVB were given placebo tablets to achieve a matching therapy procedure. During the 4 months following treatment, patient exposure to solar UVB was monitored with polysulphone badges. PLE occurrence, severity, and restriction of outdoor activity were recorded, using weekly diary-sheets. Analysis of covariance on this data, using the logarithm of UVB exposure as the explanatory variable, showed no significant differences between the treatments. TL-01 UVB is an effective alternative to PUVA in the management of PLE.

AB - Twenty-five patients suffering from severe polymorphic light eruption (PLE) were randomized to either photochemotherapy (PUVA) or narrow-band phototherapy (TL-01 UVB) treatment in early spring; patients receiving UVB were given placebo tablets to achieve a matching therapy procedure. During the 4 months following treatment, patient exposure to solar UVB was monitored with polysulphone badges. PLE occurrence, severity, and restriction of outdoor activity were recorded, using weekly diary-sheets. Analysis of covariance on this data, using the logarithm of UVB exposure as the explanatory variable, showed no significant differences between the treatments. TL-01 UVB is an effective alternative to PUVA in the management of PLE.

U2 - 10.1111/j.1365-2133.1993.tb03337.x

DO - 10.1111/j.1365-2133.1993.tb03337.x

M3 - Article

C2 - 8286256

SN - 0007-0963

VL - 129

SP - 708

EP - 712

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 6

ER -

A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption

Abstract

Access to Document

Fingerprint

Cite this